Sovateltide

DRUG3 trials

Sponsors

Pharmazz EU Limited, Pharmazz, Inc.

Conditions

Acute Cerebral IschemiaAcute Ischemic StrokeAcute cerebral ischemic strokeCerebral Stroke

Phase 3

Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke

RecruitingNCT05691244

Pharmazz, Inc.Acute Ischemic Stroke, Cerebral Stroke

Start: 2025-07-24End: 2027-12-01Target: 514Updated: 2026-09-15

A multicentric, randomized, double-blind, parallel, placebo-controlled phase III study to assess the safety and efficacy of sovateltide in patients with acute cerebral ischemic stroke.

Not yet recruitingCTIS2024-519551-29-00

Pharmazz EU LimitedAcute cerebral ischemic stroke

Target: 262Updated: 2025-08-27

Phase 4

Study to Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke

RecruitingNCT05955326

Pharmazz, Inc.Acute Cerebral Ischemia

Start: 2024-01-08End: 2026-12-01Target: 160Updated: 2026-09-17

Related Papers

Efficacy and Safety of Sovateltide in Patients with Acute Cerebral Ischaemic Stroke: A Randomised, Double-Blind, Placebo-Controlled, Multicentre, Phase III Clinical Trial

Drugs2024-11-153 citations